Amid inspection and recall woes, Aurobindo to shut down NJ site in April
An India-based generic manufacturing giant that has had its fair share of run-ins with FDA inspectors will close a New Jersey site, and eliminate 99 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
